Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for prevention of blood clot formation in ICU trauma patients
IRCT20090808002310N4Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of enoxaparin in Physical trauma and venous thromboembolism (VTE), sponsored by Shiraz University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
enoxaparin
03
Conditions
Physical traumavenous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20090808002310N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090808002310N4.